Anondita Medicare vs Colgate-Palmolive (India)
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Anondita Medicare currently has the stronger revenue growth signal.
Anondita Medicare and Colgate-Palmolive (India) show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Anondita Medicare | Colgate-Palmolive (India) |
|---|---|---|
| Current Price | ₹1,002.65 | ₹1,695 |
| Market Cap | ₹1,909.52 Cr. | ₹46,162.06 Cr. |
| Industry | Personal Products | Personal Products |
| P/E Ratio | 57.09 | 33.38 |
| ROE (%) | 40.22 | 82.73 |
| Debt/Equity | 0.26 | 0.03 |
| Sales Growth 5Y (%) | — | 4.51 |
| Profit Growth 5Y (%) | 4.49 | -20.35 |
| Promoter Holding (%) | 59.26 | 51 |
| Revenue Rank | Rank 1 | Rank 3 |
| Margin Rank | Rank 1 | Rank 4 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |
Analyze Anondita Medicare →Analyze Colgate-Palmolive (India) →Compare other stocks →Stock Screener →
Potential multibaggers · Q2 FY27
Potential multibaggers in Personal Products
on management's own guidance
- Strong growth2
- Strong growth1
- EmamiGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.